Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Investigative Radiology

• Publication date

  1997-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00004424-199712000-00004PMID 9406014
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum albumin--a non-saturable carrier.

  2009cited by this paper
• MS-325: a small-molecule vascular imaging agent for magnetic resonance imaging.

  1996cited by this paper
• Quantitation of saturation effects versus dose in three-dimensional time-of-flight magnetic resonance angiography with blood-pool contrast agents.

  1994cited by this paper
• Dynamic contrast‐enhanced MR imaging of the upper abdomen: Enhancement properties of gadobutrol, gadolinium‐DTPA‐polylysine, and gadolinium‐DTPA‐cascade‐polymer

  1994cited by this paper
• A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies.

  1993cited by this paper
• Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent.

  1993cited by this paper
• Liver contrast media for magnetic resonance imaging. Interrelations between pharmacokinetics and imaging.

  1993cited by this paper
• In vivo MR evaluation of Gd-DTPA conjugated to dextran in normal rabbits.

  1992cited by this paper
• Atomic structure and chemistry of human serum albumin

  1992cited by this paper
• Paramagnetic Dextrans as Magnetic Resonance Contrast Agents

  1991cited by this paper
• Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues.

  1990cited by this paper
• Comparison of the contrast-enhancing properties of albumin-(Gd-DTPA) and Gd-DTPA at 2.0 T: and experimental study in rats.

  1986cited by this paper

• A novel albumin-binding macrocyclic Gd-HPDO3A complex bearing a deoxycholic acid residue: the role of the hydration state, water exchange and local dynamics in the observed relaxivity

  2024influential citation
• Protein MRI Contrast Agents as an Effective Approach for Precision Molecular Imaging

  2024cites this paper
• SWOT and Root Cause Analyses of Antimicrobial Resistance to Oral Antimicrobial Treatment of Cystitis

  2024cites this paper
• Metal-Organic Polyhedron with Four Fe(III) Centers Producing Enhanced T1 Magnetic Resonance Imaging Contrast in Tumors.

  2022cites this paper
• DNA-encoded chemical libraries

  2022cites this paper
• Exploring the Influence of Different Albumin Binders on Molecular Imaging Probe Distribution.

  2021cites this paper
• Long-term safety of Gadofosveset in clinical practice.

  2021cites this paper
• How Different Albumin-Binders Drive Probe Distribution of Fluorescent RGD Mimetics

  2021cites this paper
• Phosphodiesterase-5 inhibitors ameliorate structural kidney damage in a rat model of contrast-induced nephropathy.

  2020cites this paper
• Ligand design strategies to increase stability of gadolinium-based magnetic resonance imaging contrast agents

  2019cites this paper
• Contrast Agents in Cardiovascular Magnetic Resonance Imaging

  2019cites this paper
• Lanthanide Complexes of DO3A-(Dibenzylamino)methylphosphinate: Effect of Protonation of the Dibenzylamino Group on the Water-Exchange Rate and the Binding of Human Serum Albumin.

  2019cites this paper
• Targeted Contrast Agents for Molecular MRI

  2018cites this paper
• Synthesis, Characterization, and Biodistribution of a Dinuclear Gadolinium Complex with Improved Properties as a Blood Pool MRI Agent

  2018cites this paper
• Advocating the Development of Next-Generation High-Relaxivity Gadolinium Chelates for Clinical Magnetic Resonance

  2018cites this paper
• Use of blood pool agents with steady‐state MRI to assess the vascular system

  2017cites this paper
• Exceedingly small iron oxide nanoparticles as positive MRI contrast agents

  2017cites this paper
• Historical Perspective of Imaging Contrast Agents.

  2017cites this paper
• Gd-AAZTA-MADEC, an improved blood pool agent for DCE-MRI studies on mice on 1 T scanners.

  2016cites this paper
• Chemical and in vitro characterizations of a promising bimodal AGuIX probe able to target apoptotic cells for applications in MRI and optical imaging.

  2016cites this paper
• Paramagnetic Gd(3+) labeled red blood cells for magnetic resonance angiography.

  2016cites this paper
• Facile synthesis of zwitterionic polyglycerol dendrimers with a β-cyclodextrin core as MRI contrast agent carriers

  2016cites this paper
• Equilibrium-phase MR angiography: Comparison of unspecific extracellular and protein-binding gadolinium-based contrast media with respect to image quality.

  2016cites this paper
• Magnetic resonance imaging biomarkers of cancer : with applications in high intensity focused ultrasound treatment evaluation

  2015cites this paper
• MR imaging probes: design and applications.

  2015cites this paper
• Compensatory biliary and urinary excretion of gadobenate ion after administration of gadobenate dimeglumine (MultiHance®) in cases of impaired hepatic or renal function: a mechanism that may aid in the prevention of nephrogenic systemic fibrosis?

  2015cites this paper
• Extracardiac applications of MR blood pool contrast agent in children

  2014cites this paper
• In Vivo Techniques and Strategies for Enhanced Vascularization of Engineered Bone

  2014cites this paper
• A practical guide to magnetic resonance vascular imaging: techniques and applications.

  2014cites this paper
• Bildgebung bei Venenerkrankungen

  2014cites this paper
• USPIO-loaded red blood cells as a biomimetic MR contrast agent: a relaxometric study.

  2014cites this paper
• Synthesis and Properties of a Biodegradable Dendritic Magnetic Resonance Imaging Contrast Agent

  2014cites this paper
• In Vivo Imaging Methods for the Assessment of Angiogenesis: Clinical and Experimental Applications

  2014cites this paper
• The Chemistry of Lanthanide MRI Contrast Agents

  2014cites this paper
• Contrast enhanced MR venography with gadofosveset trisodium: Evaluation of the intracranial and extracranial venous system

  2014cites this paper
• Molecular Imaging at Nanoscale with Magnetic Resonance Imaging

  2014cites this paper
• Safety aspects of gadofosveset in clinical practice--analysis of acute and long-term complications.

  2014cites this paper
• Binding of a dimeric manganese porphyrin to serum albumin: towards a gadolinium-free blood-pool T1 MRI contrast agent

  2014cites this paper
• Design, Synthesis, and Evaluation of New Biodegradable Polymers and Nanoscale Assemblies for Drug Delivery

  2013cites this paper
• Gadolinium-containing magnetic resonance contrast media: investigation on the possible transchelation of Gd³⁺ to the glycosaminoglycan heparin.

  2013cites this paper
• Targeted biodegradable dendritic MRI contrast agent for enhanced tumor imaging.

  2013cites this paper
• Gd-based macromolecules and nanoparticles as magnetic resonance contrast agents for molecular imaging.

  2013cites this paper
• Delta Relaxation Enhanced Magnetic Resonance - Development and Application of a Field-Cycling Contrast Mechanism

  2013cites this paper
• Comprehensive MRA of the lower limbs including high-resolution extended-phase infra-inguinal imaging with gadobenate dimeglumine: initial experience with inter-individual comparison to the blood-pool contrast agent gadofosveset trisodium.

  2013cites this paper
• Contrast‐enhanced magnetic resonance angiography of the peripheral arteries: Technique, tips, pitfalls and problems

  2013cites this paper
• Polymer cross-linking: a nanogel approach to enhancing the relaxivity of MRI contrast agents.

  2013cites this paper
• Pharmacokinetics and Bio-distribution of New Gd-complexes of DTPA-bis (amide) (L3) in a Rat Model

  2013cites this paper
• Characterising gadofosveset for use in quantitative MRI studies

  2013cites this paper
• Targeted MRI Contrast Agents

  2013cites this paper
• Biodistribution properties of cleistanthin A and cleistanthin B using magnetic resonance imaging in a normal and tumoric animal model

  2012cites this paper
• Facile synthesis and in vivo evaluation of biodegradable dendritic MRI contrast agents

  2012cites this paper
• Gd(III) chelates for MRI contrast agents: from high relaxivity to “smart”, from blood pool to blood–brain barrier permeable

  2012cites this paper
• Blood‐Pool and Targeting MRI Contrast Agents: From Gd‐Chelates to Gd‐Nanoparticles

  2012cites this paper
• Hepatobiliary contrast enhancement using gadofosveset trisodium

  2012cites this paper
• Advantages of blood pool contrast agents in MR angiography: A pictorial review

  2012cites this paper
• Measuring in vivo tumor pHe with CEST‐FISP MRI

  2012cites this paper
• Takayasu arteritis: intravascular contrast medium for MR angiography in the evaluation of disease activity.

  2012cites this paper
• A Historical Overview of Magnetic Resonance Imaging, Focusing on Technological Innovations

  2012cites this paper
• Characterization of tumour vasculature with dynamic contrast enhanced MRI and Gd-hyperbranched polyglycerols

  2012cites this paper
• Simultaneous MR arteriography and venography with blood pool contrast agent detects deep venous thrombosis in suspected arterial disease.

  2012cites this paper
• Novel Polysaccharide Based Polymers and Nanoparticles for Controlled Drug Delivery and Biomedical Imaging

  2012cites this paper
• A new potential contrast agent for magnetic resonance imaging: Synthesis and relaxivity studies of a gadolinium(III) complex of glucose-6-phosphate conjugated 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid

  2012cites this paper
• Gadofosveset-enhanced magnetic resonance angiography as a means of evaluating pulmonary arteriovenous malformation: a case report.

  2012cites this paper
• Characterization of carotid artery plaques with USPIO-enhanced MRI: assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability

  2011cites this paper
• Gadofosveset enhanced MR phlebography for detecting pelvic and deep vein leg thrombosis.

  2011cites this paper
• Gadofosveset-enhanced 4D magnetic resonance angiography as a means of localizing the site of post aortic graft leak.

  2011cites this paper
• The Developmental History of the Gadolinium Chelates as Intravenous Contrast Media for Magnetic Resonance

  2011cites this paper
• Synthesis and physicochemical characterization of carbon backbone modified [Gd(TTDA)(H2O)]2- derivatives.

  2011cites this paper
• Pharmacokinetics and magnetic resonance imaging of biodegradable macromolecular blood-pool contrast agent PG-Gd in non-human primates: a pilot study.

  2011cites this paper
• Uridine-based paramagnetic supramolecular nanoaggregate with high relaxivity capable of detecting primitive liver tumor lesions.

  2011cites this paper
• Investigation of the Longitudinal Relaxation Rate of Blood After Gadobenate Dimeglumine Administration: Sequence Optimization, Dynamic Acquisition, and Clinical Impact for Contrast-Enhanced MR Angiography of the Carotid Arteries

  2011cites this paper
• Synthesis of lanthanide(III) complexes appended with a diphenylphosphinamide and their interaction with human serum albumin

  2011cites this paper
• Prospective evaluation of high-resolution MRI using gadofosveset for stent-graft planning: comparison with CT angiography in 30 patients.

  2011cites this paper
• Contrast-enhanced MRA of the renal and aorto-iliac-femoral arteries: comparison of gadobenate dimeglumine and gadofosveset trisodium.

  2011cites this paper
• Dynamic T1 functional MRI examinations with use of blood pool contrast agent--an approach to optimization of the technique.

  2011cites this paper
• MRI contrast agents based on dysprosium or holmium.

  2011cites this paper
• Cardiovascular magnetic resonance imaging for in vivo assessment of the age of myocardial infarct and for identification of signifact coronary heart disease in patients with peripheral arterial disease

  2011cites this paper
• Macromolecular and dendrimer-based magnetic resonance contrast agents

  2010cites this paper
• Quantitative Evaluation of Contrast Agent Dynamics in Liver MRI

  2010cites this paper
• A blood pool contrast aided T1 functional MRI in patients with brain tumors—a preliminary study

  2010cites this paper
• Gadolinium-Based Magnetic Resonance Contrast Agents at 7 Tesla: In Vitro T1 Relaxivities in Human Blood Plasma

  2010cites this paper
• Image Acquisition Technique and Sequences Contrast-Enhanced MRA

  2010cites this paper
• MR imaging evaluation of the hepatic vasculature.

  2010cites this paper
• Albumin-based nanoparticles as magnetic resonance contrast agents: I. Concept, first syntheses and characterisation

  2010cites this paper
• High spatial resolution magnetic resonance imaging of experimental cerebral venous thrombosis with a blood pool contrast agent.

  2010cites this paper
• Gadofosveset injection for magnetic resonance angiography

  2010cites this paper
• Gadofosveset-enhanced MR imaging for the preoperative evaluation of potential living kidney donors: correlation with intraoperative findings.

  2010cites this paper
• High Spatial Resolution and High Contrast Visualization of Brain Arteries and Veins: Impact of Blood Pool Contrast Agent and Water-Selective Excitation Imaging at 3T

  2010cites this paper
• Preliminary experience with MRA in evaluating the degree of carotid stenosis and plaque morphology using high-resolution sequences after gadofosveset trisodium (Vasovist) administration: comparison with CTA and DSA

  2010cites this paper
• Synthesis and characterization of new low-molecular-weight lysine-conjugated Gd-DTPA contrast agents.

  2010cites this paper
• Gadolinium Complexes as MRI Contrast Agents for Diagnosis

  2010cites this paper
• Contrast-enhanced whole-heart coronary MRA using Gadofosveset 3.0 T versus 1.5 T.

  2010cites this paper
• Gadobenate dimeglumine and gadofosveset trisodium for MR angiography of the renal arteries: Multicenter intraindividual crossover comparison.

  2010cites this paper
• Intraindividual comparison between gadopentetate dimeglumine and gadobutrol for magnetic resonance perfusion in normal brain and intracranial tumors at 3 tesla

  2009cites this paper
• Functional imaging with MR T1 contrast: a feasibility study with blood-pool contrast agent

  2009cites this paper
• Gadofosveset-enhanced MR angiography of carotid arteries: does steady-state imaging improve accuracy of first-pass imaging? Comparison with selective digital subtraction angiography.

  2009cites this paper
• Liver vessel enhancement by gd-bopta and gd-eob-dtpa: a comparison in healthy volunteers

  2009cites this paper
• MR Angiographic Follow-Up of Intracranial Aneurysms Treated with Detachable Coils: Evaluation of a Blood-Pool Contrast Medium

  2009cites this paper
• Biodistribution of gadolinium‐based contrast agents, including gadolinium deposition

  2009cites this paper
• Coronary MR imaging: lumen and wall.

  2009cites this paper